Drug Trial Radar · NCT00296855
Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease
Last checked: Nov 20, 2026Latest source record: Apr 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
261
Actual
Start
Feb 2006
Primary completion
Not stated
Study completion Feb 2007
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Feb 27, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The particular aim of this study is the comparison of the diagnostic results of MRA images upon application of Vasovist (gadofosveset), a contrast agent not yet available on the market, with the MRA images upon application of a conventional extracellular contrast agent. A catheter angiography, which will be performed as a routine diagnostic procedure for vascular diseases, will serve as an evaluation standard.
Conditions
- Peripheral Vascular Diseases
Interventions
Vasovist (BAY86-5283, MS-325)Drug
All patients receive a single IV bolus injection of Vasovist at a dose of 0,03 mmol/kg BW at a flowrate of 0,5 mL/sec, followed by a saline flush of at least 30 mL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic potential of Vasovist enhanced MRATime frame: Imaging after baseline visit, before and after Vasovist injection
Locations
26 sites in 6 countries. Site status is shown where the registry gives one.
Site not named
Buenos Aires, Buenos Aires, Argentina
Site not named
Lornas de Zamora, Buenos Aires, Argentina
Site not named
Buenos Aires, Buenos Aires F.D., Argentina
Site not named
Buenos Aires, Buenos Aires F.D., Argentina
Site not named
Sankt Pölten, Lower Austria, Austria
Site not named
Vienna, State of Vienna, Austria
Site not named
Vienna, State of Vienna, Austria
Site not named
Graz, Styria, Austria
Site not named
Curitiba, Paraná, Brazil
Site not named
Rio de Janeiro, Rio de Janeiro, Brazil
Site not named
São Paulo, São Paulo, Brazil
Site not named
São Paulo, São Paulo, Brazil
Site not named
Hamburg, Free and Hanseatic City of Hamburg, Germany
Site not named
Frankfurt am Main, Hesse, Germany
Site not named
Frankfurt am Main, Hesse, Germany
Site not named
Bonn, North Rhine-Westphalia, Germany
Site not named
Cologne, North Rhine-Westphalia, Germany
Site not named
Essen, North Rhine-Westphalia, Germany
Site not named
Münster, North Rhine-Westphalia, Germany
Site not named
Mainz, Rhineland-Palatinate, Germany
Site not named
Berlin, State of Berlin, Germany
Site not named
Mexico D. F., Mexico
Site not named
México D.F., Mexico
Site not named
Monterrey, Nuevo León, Mexico
Site not named
Baden, Switzerland
Site not named
Basel, Basel, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.